These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 20851083

  • 1. Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows.
    Imoto J, Ishikawa T, Yamanaka A, Konishi M, Murakami K, Shibahara T, Kubo M, Lim CK, Hamano M, Takasaki T, Kurane I, Udagawa H, Mukuta Y, Konishi E.
    Vaccine; 2010 Oct 28; 28(46):7373-80. PubMed ID: 20851083
    [Abstract] [Full Text] [Related]

  • 2. Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine.
    Imoto J, Konishi E.
    Vaccine; 2007 Jan 22; 25(6):1076-84. PubMed ID: 17084490
    [Abstract] [Full Text] [Related]

  • 3. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E, Yamaoka M, Kurane I, Mason PW.
    Virology; 2000 Mar 01; 268(1):49-55. PubMed ID: 10683326
    [Abstract] [Full Text] [Related]

  • 4. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G, Jian W, Feng X, Li-ping S, Quan-yun S, Jin-ping Z, Pu-yan C, Pei-hong L.
    Vaccine; 2008 Oct 16; 26(44):5590-4. PubMed ID: 18761388
    [Abstract] [Full Text] [Related]

  • 5. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
    Sheng Z, Gao N, Cui X, Fan D, Chen H, Wu N, Wei J, An J.
    Vaccine; 2016 Nov 11; 34(47):5751-5757. PubMed ID: 27743649
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K, Rani R, Vrati S.
    Vaccine; 2009 Jan 01; 27(1):10-6. PubMed ID: 18996161
    [Abstract] [Full Text] [Related]

  • 7. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
    Kikukawa A, Gomi Y, Akechi M, Onishi T, Manabe S, Namazue J, Fuke I, Ishikawa T, Okuno Y, Ueda S.
    Vaccine; 2012 Mar 16; 30(13):2329-35. PubMed ID: 22306856
    [Abstract] [Full Text] [Related]

  • 8. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S.
    Vaccine; 2011 Aug 11; 29(35):5925-31. PubMed ID: 21723353
    [Abstract] [Full Text] [Related]

  • 9. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine.
    Lim CK, Takasaki T, Kotaki A, Kurane I.
    Virology; 2008 Apr 25; 374(1):60-70. PubMed ID: 18221765
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
    Woolpert T, Staples JE, Faix DJ, Nett RJ, Kosoy OI, Biggerstaff BJ, Johnson BW, Sracic M, Fischer M.
    Vaccine; 2012 Apr 26; 30(20):3090-6. PubMed ID: 22406277
    [Abstract] [Full Text] [Related]

  • 11. Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model.
    Imoto J, Konishi E.
    Viral Immunol; 2005 Apr 26; 18(1):205-12. PubMed ID: 15802965
    [Abstract] [Full Text] [Related]

  • 12. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.
    J Infect Dis; 2003 Oct 15; 188(8):1213-30. PubMed ID: 14551893
    [Abstract] [Full Text] [Related]

  • 13. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
    Yun KW, Lee HJ, Park JY, Cho HK, Kim YJ, Kim KH, Kim NH, Hong YJ, Kim DH, Kim HM, Cha SH.
    Vaccine; 2018 Mar 07; 36(11):1398-1404. PubMed ID: 29429815
    [Abstract] [Full Text] [Related]

  • 14. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 May 27; 60(20):661-3. PubMed ID: 21617632
    [Abstract] [Full Text] [Related]

  • 15. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
    Paulke-Korinek M, Kollaritsch H, Kundi M, Zwazl I, Seidl-Friedrich C, Jelinek T.
    Vaccine; 2015 Jul 09; 33(30):3600-4. PubMed ID: 26036947
    [Abstract] [Full Text] [Related]

  • 16. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M, Johnes S, Li L, Heath A, Barrett A.
    Biologicals; 2008 Mar 09; 36(2):111-6. PubMed ID: 17892945
    [Abstract] [Full Text] [Related]

  • 17. [Long-term seroprotection against Japanese encephalitis using an inactivated vaccine (Jevax)].
    Van der Vliet D, Simons de Fanti A, Murri S, Lapidus N, Goujon C, Zeller H, Consigny PH.
    Med Trop (Mars); 2010 Apr 09; 70(2):155-7. PubMed ID: 20486351
    [Abstract] [Full Text] [Related]

  • 18. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, Lindquist L, Vapalahti O, Kantele A.
    Vaccine; 2013 Dec 17; 32(1):119-23. PubMed ID: 24176496
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP.
    Virology; 1999 May 10; 257(2):363-72. PubMed ID: 10329547
    [Abstract] [Full Text] [Related]

  • 20. Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China.
    Zheng X, Yu X, Wang Y, Turtle L, Cui M, Wang R, Yin C.
    Virol J; 2020 Aug 24; 17(1):126. PubMed ID: 32831096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.